This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 535.61M 230.28M 483.61M 112.57M
Receivables 891.78M 693.12M 103.04M 93.11M
Inventories 70.35M 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 1.80B 1.21B 652.88M 357.62M
Property, Plant & Equipment, Gross 748.60M 560.45M 526.09M 478.76M
Accumulated Depreciation & Depletion 221.62M 180.51M 158.14M 131.31M
Property, Plant & Equipment, Net 526.98M 379.94M 367.96M 347.45M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 395.22M 302.52M 302.75M 384.36M
Total Non-Current Assets 1.15B 874.48M 670.71M 731.81M
Liabilities & Shareholder Equity
Total Assets 2.95B 2.08B 1.32B 1.09B
Accounts Payable 61.94M 38.93M 27.74M 2.25M
Short Term Debt 939.00K 1.37M 1.01M 675.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 298.84M 163.55M 148.27M 109.06M
Long Term Debt 320.32M 296.52M 275.02M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 195.53M 215.60M 255.05M 293.21M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 700.10M 671.56M 689.58M 452.56M
Total Liabilities 998.94M 835.10M 837.85M 561.62M
Preferred Stock Equity 0.00 2.00K 2.00K 0.00
Common Stock Equity 1.95B 1.25B 485.73M 527.82M
Common Par 99.00K 95.00K 91.00K 89.00K
Additional Paid In Capital 2.05B 1.76B 1.75B 1.58B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -92.69M -517.05M -1.27B -1.05B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -1.19M -1.17M -1.86M -2.49M
Total Capitalization 2.27B 1.54B 760.75M 527.82M
Total Equity 1.95B 1.25B 485.73M 527.82M
Total Liabilities & Stock Equity 2.95B 2.08B 1.32B 1.09B
Total Common Shares Outstanding 99.69M 97.29M 92.80M 89.42M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 97.92M 94.68M 90.61M 82.93M
Diluted Weighted Shares Outstanding 111.29M 115.38M 90.61M 82.93M
Number of Employees 2340 1950 1704 1395
Number of Part-Time Employees 0 0 0 0

REGN Regeneron Pharmaceuticals Inc

Analysts Ratings for REGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 9 9 9
Moderate Buy 1 1 1 1
Hold 6 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

REGN Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs